NEW YORK (GenomeWeb News) — The National Institute of Mental Health plans to grant around $2 million to investigators who are studying ways to apply pharmacogenomics and personalized medicine technologies and techniques to the treatment of depression, the National Institutes of Health announced last week.

 

The goal of the project, which will support around seven researchers for up to three years, is to test new approaches and to develop models that will integrate specific patient characteristics into the treatment of depression.